Revance Therapeutics Inc (RVNC)
NASDAQ
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -37.182 | -48.229 | -54.619 | -56.272 | -53.199 | -44.96 | -64.043 | -61.109 |
| Return on Equity (%) | -41.49 | -54.085 | -68.796 | -85.92 | -94.064 | -127.071 | -879.284 | 466.153 |
| Return on Invested Capital (%) | -36.451 | -52.752 | -71.169 | -90.18 | -68.415 | -58.886 | -71.466 | -76.956 |
| Operating Margin (%) | -29396 | -45851.145 | -3741.593 | -38602.663 | -1758.962 | -353.527 | -255.911 | -130.033 |
| Net Profit Margin (%) | -29756.667 | -46025.573 | -3823.223 | -38602.663 | -1840.711 | -361.59 | -268.866 | -138.432 |
| Book Value Per Share | 6.26 | 7.362 | 3.938 | 4.305 | 2.255 | -1.87 | -1.112 | -1.838 |
| Earnings Per Share | -3.156 | -3.302 | -3.856 | -3.044 | -4.078 | -3.93 | -4.326 | -3.689 |
| Cash Per Share | 2.245 | 7.747 | 1.981 | 3.255 | 4.822 | 1.545 | 1.323 | 1.564 |
| Working Capital Per Share | 6.117 | 7.238 | 4.759 | 4.881 | 5.624 | 2.498 | 3.63 | 2.843 |
| Operating Profit Per Share | 0.011 | 0.007 | 0.101 | 0.008 | 0.153 | 0.76 | 0.982 | 1.818 |
| EBIT Per Share | -3.156 | -3.302 | -3.775 | -3.044 | -4.116 | -3.93 | -4.318 | -3.686 |
| EBITDA Per Share | -3.156 | -3.302 | -3.775 | -3.044 | -4.116 | -3.93 | -4.318 | -3.686 |
| Free Cash Flow Per Share | -3.148 | -3.274 | -3.713 | -3.038 | -4.165 | -4.062 | -4.697 | -3.767 |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 28.29M | 36.52M | 36.98M | 52.38M | 69.18M | 71.58M | 82.39M | N/A |
| Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Shares Outstanding | 82.39M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | -112.092 | N/A | N/A | N/A | -85.238 | N/A | N/A |
| Net Profit Margin (%) | N/A | -121.208 | N/A | N/A | N/A | -102.341 | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 355.62M |
| Price to Earnings Ratio | -1.1 |
| Price to Sales Ratio | 1.52 |
| Price to Cash Ratio | 2.59 |
| Price to Book Ratio | -2.35 |
| Dividend Yield | - |
| Shares Outstanding | 104.9M |
| Average Volume (1 week) | 4.46M |
| Average Volume (1 Month) | 3.07M |
| 52 Week Change | -51.57% |
| 52 Week High | 7.587 |
| 52 Week Low | 2.30 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
